Physician profile
Melissa Nameth
NPI 1518566900
$6,930.28
in general payments reported to CMS, 2019-2025
38 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $836 · 2022: $1,282 · 2023: $1,738 · 2024: $1,646 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,797 · Education: $15.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,797.34 |
| Education | $15.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,392.18 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,092.42 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $423.94 | 2023-2025 | Cologuard Collection Kit |
| Ibsa Pharma INC. | $420.23 | 2021-2025 | Tirosint, Licart, Tirosint |
| Antares Pharma, INC. | $282.60 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Abbott Laboratories | $245.62 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Corcept Therapeutics | $245.04 | 2024-2025 | Korlym |
| Aimmune Therapeutics, INC. | $212.53 | 2024-2025 | Zenpep |
| Corium, LLC | $206.74 | 2022-2024 | Azstarys |
| Pfizer INC. | $190.96 | 2022-2025 | |
| Novo Nordisk INC | $176.05 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $175.59 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $162.38 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $158.87 | 2022 | |
| Lilly USA, LLC | $132.28 | 2021-2025 | Mounjaro, Kisunla, Zepbound |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Nameth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.